HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

cis-Diammine (glycolato)platinum

HCID 72120
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
95734-82-0
Standard SMILES
O=C(O)CO.[NH2-].[NH2-].[Pt+2]
InChIKey
KLNFSAOEKUDMFA-UHFFFAOYSA-N
Molecular formula
C2H8N2O3Pt
Average molar mass
303.18 g/mol
Monoisotopic mass
303.018286

Overview

See also: Nedaplatin (annotation moved to).

Names & identifiers

Preferred name
cis-Diammine (glycolato)platinum
IUPAC
azanide;2-hydroxyacetic acid;platinum(2+)
English name
Nedaplatin
Molecular formula
C2H6N2O3Pt
Molecular weight
301.17

Names & synonyms

Nedaplatin [INN]cis-Diammine (glycolato)platinumNCGC00181152-01cis-Diammine(glycolato-O(sup 1),O(sup 2))platinumPlatinum,O(2))-, (SP-4-3)-Platinum,O(2)]-, (SP-4-3)-CCRIS 4088UNII-8UQ3W6JXANAqupla (TN)Nedaplatin (JAN/INN)Tox21_112756NSC375101
Show more names
254-sAquplaNedaplaitNEDAPLATINNidaplatinNSC 375101DNedaplatin, >=99%Nedaplatin USP/EP/BPNedaplatin (NSC 375101D)cis-diammine(glycolato)platinum(ii)
Platinum, diammine(hydroxy-kappaO)acetato(2-)-kappaO)-, (SP-4-3)-AKOS015854028Platinum, diammine(hydroxyacetato(2-)-O(sup 1),O(sup 2))-, (SP-4-3)-AC-1433NSC-375101CAS-95734-82-0D01416Bis(azanido)[(oxido-kappaO)acetato-kappaO]platinum

Database identifiers

CAS
95734-82-0
PubChem CID
72120
DTXSID
DTXSID8046878

Properties

Computed structural properties

Topological polar surface area
59.5 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
5
Rotatable bonds
0
Heavy atoms
8
Formal charge
0
Complexity
50.5

Physicochemical properties

storage temp.
-20 °C · Inert atmosphere,Store in freezer, under -20°C
solubility
2 O · H2O : 13.6 mg/mL (44.86 mM; Need ultrasonic and warming; DMSO can inactivate Nedaplatin's activity)DMF : < 1 mg/mL (insoluble; DMSO can inactivate Nedaplatin's activity)
form
Powder
color
Light yellow to yellow
InChI
InChI=1S/C2H3O3.2H2N.Pt/c3-1-2(4)5;;;/h1H2,(H,4,5);2*1H2;/q3*-1;+4/p-1
InChIKey
GRHLMSBCOPRFNA-UHFFFAOYSA-M
SMILES
N[Pt+2]1([O-]CC(=O)[O-]1)N
FDA UNII
8 UQ3W6JXAN · 8UQ3W6JXAN
NCI Drug Dictionary
nedaplatin
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
280 · P280-P305+P351+P338
target organs
Respiratory system
WGK Germany
3 · WGK 3
Storage Class
6.1 A · 6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials
Hazard Classifications
2 OralCarc · Acute Tox. 2 OralCarc. 1BEye Irrit. 2Resp. Sens. 1BSkin Irrit. 2Skin Sens. 1BSTOT SE 3

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 3
Signal word
Warning
Symbol(GHS)
GHS07
Storage Class
6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials
target organs
Respiratory system
Hazard statements
H302
Hazard Classifications
Acute Tox. 2 OralCarc. 1BEye Irrit. 2Resp. Sens. 1BSkin Irrit. 2Skin Sens. 1BSTOT SE 3
Precautionary statements
P280-P305+P351+P338

Chemistry & industry

Applications · 3 items

DescriptionNedaplatin, a novel second generation platinum complex, was marketed in Japan for the treatment of a variety of cancers including: head and neck, small-cell and non-small cell lung, oesophageal, prostatic, testicular, ovarian, cervical, bladder, and uterine cancers. Platinum anticancer agents, prototyped by cisplatin, have been reported to be hydrolyzed to the mono- or diaquated species of diamine platinum which react with nucleophilic sites on DNA to cause intrastrand and interstrand crosslinks and DNA-protein crosslinks, which result in cytotoxicity. Nedaplatin was reportedly more active than cisplatin against several solid tumors while sharing less nephro- and gastrointestinal toxicity to cisplatin in viva The minimal renal toxicity displayed by nedaplatin allows its use in patients with deteriorated renal function.

Usesanticancer

UsesNedaplatin is a platinum complex that has potent antineoplatic activity.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes